Lifeline Biotechnologies, Inc. (LLBO)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Jan 22, 2026
Lifeline Biotechnologies Statistics
Total Valuation
LLBO has a market cap or net worth of 3.04 million.
| Market Cap | 3.04M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
LLBO has 4.35 billion shares outstanding.
| Current Share Class | 4.35B |
| Shares Outstanding | 4.35B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +14.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.08.
| Current Ratio | 8.42 |
| Quick Ratio | 8.42 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -8.46% |
| Weighted Average Cost of Capital (WACC) | 1,538.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +600.00% in the last 52 weeks. The beta is 323.24, so LLBO's price volatility has been higher than the market average.
| Beta (5Y) | 323.24 |
| 52-Week Price Change | +600.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 49.74 |
| Average Volume (20 Days) | 725,083 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.34 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -562,876 |
| Pretax Income | -574,268 |
| Net Income | -574,268 |
| EBITDA | n/a |
| EBIT | -562,876 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 603,322 in cash and 481,572 in debt, with a net cash position of 121,750 or 0.00 per share.
| Cash & Cash Equivalents | 603,322 |
| Total Debt | 481,572 |
| Net Cash | 121,750 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.11M |
| Book Value Per Share | 0.00 |
| Working Capital | 531,706 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LLBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -18.86% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2008. It was a reverse split with a ratio of 0.00666.
| Last Split Date | Sep 5, 2008 |
| Split Type | Reverse |
| Split Ratio | 0.00666 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |